Grupo Fleury
Maria Carolina Castro is a seasoned business manager currently leading the Infusion business unit at Grupo Fleury, focusing on therapies for autoimmune and rare diseases. With extensive experience in business P&L ownership, strategic planning, business development, and integration after mergers and acquisitions, Maria has effectively managed strategic initiatives to enhance patient journeys and foster relationships with pharmaceutical companies and physicians. Prior roles include Strategic Projects Coordinator at Claro Brasil, where responsibilities encompassed digital transformation and project management, as well as significant tenure at Alvarez & Marsal, where performance improvement and restructuring were primary focuses. Maria holds an Executive MBA from Insper Instituto de Ensino e Pesquisa and a Bachelor's degree in Business Administration from Pontifícia Universidade Católica de São Paulo, supplemented by international business studies at NEOMA Business School.
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.